Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Sell
17,568
-3,457
-16% -$81.8K ﹤0.01% 1068
2026
Q1
$459K Sell
21,025
-3,016
-13% -$69.9K 0.01% 990
2025
Q4
$566K Sell
24,041
-2,766
-10% -$66.7K 0.01% 867
2025
Q3
$759K Buy
26,807
+10,582
+65% +$281K 0.01% 726
2025
Q2
$357K Buy
16,225
+4,803
+42% +$105K 0.01% 1075
2025
Q1
$266K Sell
11,422
-3,089
-21% -$79K ﹤0.01% 1166
2024
Q4
$415K Buy
14,511
+3,154
+28% +$94.4K 0.01% 999
2024
Q3
$335K Buy
11,357
+356
+3% +$11.1K ﹤0.01% 1141
2024
Q2
$370K Buy
+11,001
New +$380K 0.01% 980

Other funds holding GNTX

Choreo LLC's GNTX Position: Q2 2026 in Review

Choreo LLC reduced its Gentex (GNTX) stake by 16% in Q2 2026, selling an estimated $81.8K and leaving 17,568 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

Choreo LLC first reported a position in GNTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $759K in Q3 2025. 531 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Choreo LLC held 17,568 shares of Gentex worth $444K as of Q2 2026.
  • Choreo LLC sold 3,457 Gentex shares in Q2 2026, an estimated $81.8K.
  • Gentex made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1068 holding.
  • Choreo LLC first reported a position in Gentex in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Gentex position peaked at $759K in Q3 2025.
  • 531 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.